EHR

OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™

OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™

HealthVerity expands access to advanced imaging data through OneMedNet integration, enhancing evidence generation for life sciences research PHILADELPHIA and MINNEAPOLIS,…

2 weeks ago
OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™

OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™

HealthVerity expands access to advanced imaging data through OneMedNet integration, enhancing evidence generation for life sciences research PHILADELPHIA and MINNEAPOLIS,…

2 weeks ago
OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™

OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™

HealthVerity expands access to advanced imaging data through OneMedNet integration, enhancing evidence generation for life sciences research PHILADELPHIA and MINNEAPOLIS,…

2 weeks ago
Axtria Launches LUCCID to Transform Clinical Data Management with GenAIAxtria Launches LUCCID to Transform Clinical Data Management with GenAI

Axtria Launches LUCCID to Transform Clinical Data Management with GenAI

Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --…

2 weeks ago
Axtria Launches LUCCID to Transform Clinical Data Management with GenAIAxtria Launches LUCCID to Transform Clinical Data Management with GenAI

Axtria Launches LUCCID to Transform Clinical Data Management with GenAI

Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --…

2 weeks ago
Axtria Launches LUCCID to Transform Clinical Data Management with GenAIAxtria Launches LUCCID to Transform Clinical Data Management with GenAI

Axtria Launches LUCCID to Transform Clinical Data Management with GenAI

Delivers Technology for Automating Unstructured Clinical Data Extraction with Over 90% Accuracy BERKELEY HEIGHTS, N.J., April 29, 2025 /PRNewswire/ --…

2 weeks ago
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated BalloonOrchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has…

2 weeks ago
Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated BalloonOrchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has…

2 weeks ago
Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disordersBreaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Ingelheim, Germany, Oxford and Belfast, UK, April 29, 2025 – Boehringer Ingelheim, the University of Oxford, and Cumulus Neuroscience are joining…

2 weeks ago
Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disordersBreaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

Ingelheim, Germany, Oxford and Belfast, UK, April 29, 2025 – Boehringer Ingelheim, the University of Oxford, and Cumulus Neuroscience are joining…

2 weeks ago
Show more Posts
Show previous Posts